Comparison Between Platelet Rich Plasma (PRP) Injections and Corticosteroids for the Treatment of Chronic Plantar Fasciitis
Main Article Content
Abstract
Introduction: Plantar fasciitis is a common cause of heel pain. It is a clinical diagnosis, with patients classically experiencing particularly severe pain with the first few steps in the morning. Although it is often a self-limiting condition, the severity of the pain warrants medical attention. Symptoms will subside more quickly if risk factors are addressed and various treatment approaches are initiated as soon as possible.
Objective: The aim of this study was to evaluate and compare the clinical effectiveness of platelet-rich plasma (PRP) versus corticosteroid (Cs) injections in the treatment of chronic plantar fasciitis.
Methods: This prospective randomized comparative study was conducted over 12 months at Ghazi Al-Hariri Hospital and Baghdad Medical City. The study included 40 patients with chronic plantar fasciitis (symptoms > 3 months) who had failed conservative therapy. Participants were randomly assigned to two groups:
Group I (PRP): Received 5–6 ml of PRP.
Group II (Cs): Received 40 mg of methylprednisolone.
Pain was evaluated using the Numeric Pain Rating Scale (NPRS) at rest and during movement at baseline, 1 day, 10 days, and 1 month post-injection.
Results: Both groups demonstrated a significant reduction in pain scores and improved functional outcomes as time progressed. While pain decreased in both cohorts, the corticosteroid group experienced a more rapid improvement compared to the PRP group. A statistically significant difference favoring the steroid group was found at 10 days post-injection during movement (p=0.02). However, by the one-month follow-up, no statistically significant difference in pain relief was observed between the two groups. Additionally, the study noted that female gender and higher body weight were associated with significantly higher pain scores.
Conclusion: Both PRP and corticosteroid injections are effective treatments for providing symptomatic relief in chronic plantar fasciitis. Corticosteroids appear to offer faster short-term pain reduction, particularly within the first 10 days following intervention.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Riddle DL, Schappert SM. Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis: a national study of medical doctors. Foot Ankle Int. 2004 May. 25(5):303-10.
II. Buchanan BK, Kushner D. Plantar Fasciitis. InStatPearls 2020 Jun 7. StatPearls Publishing.
III. Latt LD, Jaffe DE, Tang Y, Taljanovic MS. Evaluation and Treatment of Chronic Plantar Fasciitis. Foot & Ankle Orthopaedics. January 2020.
IV. Petraglia F, Ramazzina I, Costantino C. Plantar fasciitis in athletes: diagnostic and treatment strategies. A systematic review. Muscles Ligaments Tendons J. 2017;7(1):107-118. Published 2017 May 10.
V. Brian J. Cole, MD, MBA, and H. Ralph Schumacher, Jr, MD. Injectable Corticosteroids in Modern Practice.J Am Acad Orthop Surg 2005;13:37-46.
VI. Genovese MC: Joint and soft-tissue injection: A useful adjuvant to systemic and local treatment. Postgrad Med 1998; 103:125-134.
VII. Malanga, Gerard A., and Victor Ibrahim. Regenerative Treatments in Sports and Orthopedic Medicine. Demos Medical, an Imprint of Springer Publishing, 2018.
VIII. Kaux JF, Emonds-Alt T. The use of platelet-rich plasma to treat chronic tendinopathies: A technical analysis. Platelets. 2018 Apr 3;29(3):213-27.
IX. Shetty N, Shetty V, Shetty S. A Comparative Prospective Study of Platelet Rich Plasma vs. Corticosteroid Injection in Plantar Fasciitis not Responding to 6 Weeks of Conservative Treatment. Int J Foot Ankle. 2018;2(008).
X. Lemont H, Ammirati KM, Usen N (2003) Plantar fasciitis: A degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc 93: 234-237.
XI. Ragab EM, Othman A (2012) Platelets rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg 132: 1065-1070.
XII. Soraganvi P, Nagakiran KV, Raghavendra-Raju RP, Anilkumar D, Wooly S, Basti BD, Janakiraman P. Is Platelet-rich Plasma Injection more Effective than Steroid Injection in the Treatment of Chronic Plantar Fasciitis in Achieving Long-term Relief?. Malaysian orthopaedic journal. 2019 Nov;13(3):8.
XIII. Comparison of platelet-rich plasma and steroid injection in the treatment of plantar fasciitis Correspondence: Ferhat SAY, MD, Asst. Prof. Ondokuz Mayıs Üniversitesi Tıp Fakültesi . 2014;48(6):667-672.
XIV. Lee TG, Ahmad TS. Intralesional autologous blood injection compared to corticosteroid injection for treatment of chronic plantar fasciitis: a prospective, randomized, controlled trial. Foot Ankle Int. 2007; 28: 984-90
XV. karimzadeh, A., Raeissadat, S.A., Erfani Fam, S. et al. Autologous whole blood versus corticosteroid local injection in treatment of plantar fasciitis: A randomized, controlled multicenter clinical trial. Clin Rheumatol 36, 661–669 (2017).
XVI. Wilson JJ, Lee KS, Miller AT, Wang S. Platelet-rich plasma for the treatment of chronic planter fasciopathy in adults: a case series. Foot Ankle Spec. 2014; 7(1): 61-7
XVII. Tsai WC1, Wang CL, Tang FT, Hsu TC, Hsu KH, Wong MK. Treatment of proximal plantar fasciitis with ultrasound-guided steroid injection. Arch Phys Med Rehab. 2000; 81: 1416-21.
XVIII. Jain SK, Suprashant K, Kumar S, Yadav A, Kearns SR. Comparisom of plantar fasciitis injected with platelet-rich plasma vs corticosteroids. Foot Ankle Int. 2018 Jul; 39(7): 780-6.
XIX. Akşahin E, Doğruyol D, Yüksel HY, Hapa O, Doğan O, et al. (2012) The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg 132: 781-785.
XX. Tsikopoulos, K., Tsikopoulos, A., & Natsis, K. (2016). Autologous whole blood or corticosteroid injections for the treatment of epicondylopathy and plantar fasciopathy? A systematic review and meta-analysis of randomized controlled trials. Physical Therapy in Sport.,10.
XXI. Tu P, Bytomski JR. Diagnosis of heel pain. Am Fam Physician. 2011;84(8):909–916.